0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Aldult CAR T-cell Therapy Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-34G17559
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Aldult CAR T cell Therapy Market Research Report 2024
BUY CHAPTERS

Global Aldult CAR T-cell Therapy Market Research Report 2024

Code: QYRE-Auto-34G17559
Report
August 2024
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Aldult CAR T-cell Therapy Market

The global Aldult CAR T-cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Aldult CAR T-cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Aldult CAR T-cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Aldult CAR T-cell Therapy in Multiple Myeloma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Aldult CAR T-cell Therapy include Bristol Myers Squibb,BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Aldult CAR T-cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aldult CAR T-cell Therapy.
The Aldult CAR T-cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aldult CAR T-cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aldult CAR T-cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Aldult CAR T-cell Therapy Market Report

Report Metric Details
Report Name Aldult CAR T-cell Therapy Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol Myers Squibb,BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Aldult CAR T-cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Aldult CAR T-cell Therapy Market report?

Ans: The main players in the Aldult CAR T-cell Therapy Market are Bristol Myers Squibb,BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics

What are the Application segmentation covered in the Aldult CAR T-cell Therapy Market report?

Ans: The Applications covered in the Aldult CAR T-cell Therapy Market report are Multiple Myeloma, B-Cell Lymphoma (BCL), Acute Lymphoblastic Leukemia (ALL), Others

What are the Type segmentation covered in the Aldult CAR T-cell Therapy Market report?

Ans: The Types covered in the Aldult CAR T-cell Therapy Market report are CD19, BCMA, Others

Recommended Reports

CAR-T Cell Therapy

Cell Therapy Technologies

Stem Cell Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aldult CAR T-cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CD19
1.2.3 BCMA
1.2.4 Others
1.3 Market by Application
1.3.1 Global Aldult CAR T-cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Multiple Myeloma
1.3.3 B-Cell Lymphoma (BCL)
1.3.4 Acute Lymphoblastic Leukemia (ALL)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aldult CAR T-cell Therapy Market Perspective (2019-2030)
2.2 Global Aldult CAR T-cell Therapy Growth Trends by Region
2.2.1 Global Aldult CAR T-cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Aldult CAR T-cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Aldult CAR T-cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Aldult CAR T-cell Therapy Market Dynamics
2.3.1 Aldult CAR T-cell Therapy Industry Trends
2.3.2 Aldult CAR T-cell Therapy Market Drivers
2.3.3 Aldult CAR T-cell Therapy Market Challenges
2.3.4 Aldult CAR T-cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Aldult CAR T-cell Therapy Players by Revenue
3.1.1 Global Top Aldult CAR T-cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Aldult CAR T-cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Aldult CAR T-cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Aldult CAR T-cell Therapy Revenue
3.4 Global Aldult CAR T-cell Therapy Market Concentration Ratio
3.4.1 Global Aldult CAR T-cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aldult CAR T-cell Therapy Revenue in 2023
3.5 Global Key Players of Aldult CAR T-cell Therapy Head office and Area Served
3.6 Global Key Players of Aldult CAR T-cell Therapy, Product and Application
3.7 Global Key Players of Aldult CAR T-cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Aldult CAR T-cell Therapy Breakdown Data by Type
4.1 Global Aldult CAR T-cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Aldult CAR T-cell Therapy Forecasted Market Size by Type (2025-2030)
5 Aldult CAR T-cell Therapy Breakdown Data by Application
5.1 Global Aldult CAR T-cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Aldult CAR T-cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Aldult CAR T-cell Therapy Market Size (2019-2030)
6.2 North America Aldult CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Aldult CAR T-cell Therapy Market Size by Country (2019-2024)
6.4 North America Aldult CAR T-cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Aldult CAR T-cell Therapy Market Size (2019-2030)
7.2 Europe Aldult CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Aldult CAR T-cell Therapy Market Size by Country (2019-2024)
7.4 Europe Aldult CAR T-cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Aldult CAR T-cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Aldult CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Aldult CAR T-cell Therapy Market Size (2019-2030)
9.2 Latin America Aldult CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Aldult CAR T-cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Aldult CAR T-cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Aldult CAR T-cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Aldult CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol Myers Squibb,BMS
11.1.1 Bristol Myers Squibb,BMS Company Details
11.1.2 Bristol Myers Squibb,BMS Business Overview
11.1.3 Bristol Myers Squibb,BMS Aldult CAR T-cell Therapy Introduction
11.1.4 Bristol Myers Squibb,BMS Revenue in Aldult CAR T-cell Therapy Business (2019-2024)
11.1.5 Bristol Myers Squibb,BMS Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Aldult CAR T-cell Therapy Introduction
11.2.4 Johnson & Johnson Revenue in Aldult CAR T-cell Therapy Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Aldult CAR T-cell Therapy Introduction
11.3.4 Gilead Sciences Revenue in Aldult CAR T-cell Therapy Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Aldult CAR T-cell Therapy Introduction
11.4.4 Novartis Revenue in Aldult CAR T-cell Therapy Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Aldult CAR T-cell Therapy Introduction
11.5.4 JW Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2019-2024)
11.5.5 JW Therapeutics Recent Development
11.6 Imunopharm Technology Co., Ltd.
11.6.1 Imunopharm Technology Co., Ltd. Company Details
11.6.2 Imunopharm Technology Co., Ltd. Business Overview
11.6.3 Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Introduction
11.6.4 Imunopharm Technology Co., Ltd. Revenue in Aldult CAR T-cell Therapy Business (2019-2024)
11.6.5 Imunopharm Technology Co., Ltd. Recent Development
11.7 CARsgen Therapeutics
11.7.1 CARsgen Therapeutics Company Details
11.7.2 CARsgen Therapeutics Business Overview
11.7.3 CARsgen Therapeutics Aldult CAR T-cell Therapy Introduction
11.7.4 CARsgen Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2019-2024)
11.7.5 CARsgen Therapeutics Recent Development
11.8 Cartesian Therapeutics
11.8.1 Cartesian Therapeutics Company Details
11.8.2 Cartesian Therapeutics Business Overview
11.8.3 Cartesian Therapeutics Aldult CAR T-cell Therapy Introduction
11.8.4 Cartesian Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2019-2024)
11.8.5 Cartesian Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Aldult CAR T-cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of CD19
 Table 3. Key Players of BCMA
 Table 4. Key Players of Others
 Table 5. Global Aldult CAR T-cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Aldult CAR T-cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Aldult CAR T-cell Therapy Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Aldult CAR T-cell Therapy Market Share by Region (2019-2024)
 Table 9. Global Aldult CAR T-cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Aldult CAR T-cell Therapy Market Share by Region (2025-2030)
 Table 11. Aldult CAR T-cell Therapy Market Trends
 Table 12. Aldult CAR T-cell Therapy Market Drivers
 Table 13. Aldult CAR T-cell Therapy Market Challenges
 Table 14. Aldult CAR T-cell Therapy Market Restraints
 Table 15. Global Aldult CAR T-cell Therapy Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Aldult CAR T-cell Therapy Market Share by Players (2019-2024)
 Table 17. Global Top Aldult CAR T-cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aldult CAR T-cell Therapy as of 2023)
 Table 18. Ranking of Global Top Aldult CAR T-cell Therapy Companies by Revenue (US$ Million) in 2023
 Table 19. Global 5 Largest Players Market Share by Aldult CAR T-cell Therapy Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Aldult CAR T-cell Therapy, Headquarters and Area Served
 Table 21. Global Key Players of Aldult CAR T-cell Therapy, Product and Application
 Table 22. Global Key Players of Aldult CAR T-cell Therapy, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Aldult CAR T-cell Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Aldult CAR T-cell Therapy Revenue Market Share by Type (2019-2024)
 Table 26. Global Aldult CAR T-cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Aldult CAR T-cell Therapy Revenue Market Share by Type (2025-2030)
 Table 28. Global Aldult CAR T-cell Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Aldult CAR T-cell Therapy Revenue Market Share by Application (2019-2024)
 Table 30. Global Aldult CAR T-cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Aldult CAR T-cell Therapy Revenue Market Share by Application (2025-2030)
 Table 32. North America Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. North America Aldult CAR T-cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 34. North America Aldult CAR T-cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 35. Europe Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. Europe Aldult CAR T-cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 37. Europe Aldult CAR T-cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Asia-Pacific Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region (2019-2024) & (US$ Million)
 Table 40. Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region (2025-2030) & (US$ Million)
 Table 41. Latin America Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Latin America Aldult CAR T-cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 43. Latin America Aldult CAR T-cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 44. Middle East & Africa Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Bristol Myers Squibb,BMS Company Details
 Table 48. Bristol Myers Squibb,BMS Business Overview
 Table 49. Bristol Myers Squibb,BMS Aldult CAR T-cell Therapy Product
 Table 50. Bristol Myers Squibb,BMS Revenue in Aldult CAR T-cell Therapy Business (2019-2024) & (US$ Million)
 Table 51. Bristol Myers Squibb,BMS Recent Development
 Table 52. Johnson & Johnson Company Details
 Table 53. Johnson & Johnson Business Overview
 Table 54. Johnson & Johnson Aldult CAR T-cell Therapy Product
 Table 55. Johnson & Johnson Revenue in Aldult CAR T-cell Therapy Business (2019-2024) & (US$ Million)
 Table 56. Johnson & Johnson Recent Development
 Table 57. Gilead Sciences Company Details
 Table 58. Gilead Sciences Business Overview
 Table 59. Gilead Sciences Aldult CAR T-cell Therapy Product
 Table 60. Gilead Sciences Revenue in Aldult CAR T-cell Therapy Business (2019-2024) & (US$ Million)
 Table 61. Gilead Sciences Recent Development
 Table 62. Novartis Company Details
 Table 63. Novartis Business Overview
 Table 64. Novartis Aldult CAR T-cell Therapy Product
 Table 65. Novartis Revenue in Aldult CAR T-cell Therapy Business (2019-2024) & (US$ Million)
 Table 66. Novartis Recent Development
 Table 67. JW Therapeutics Company Details
 Table 68. JW Therapeutics Business Overview
 Table 69. JW Therapeutics Aldult CAR T-cell Therapy Product
 Table 70. JW Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2019-2024) & (US$ Million)
 Table 71. JW Therapeutics Recent Development
 Table 72. Imunopharm Technology Co., Ltd. Company Details
 Table 73. Imunopharm Technology Co., Ltd. Business Overview
 Table 74. Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Product
 Table 75. Imunopharm Technology Co., Ltd. Revenue in Aldult CAR T-cell Therapy Business (2019-2024) & (US$ Million)
 Table 76. Imunopharm Technology Co., Ltd. Recent Development
 Table 77. CARsgen Therapeutics Company Details
 Table 78. CARsgen Therapeutics Business Overview
 Table 79. CARsgen Therapeutics Aldult CAR T-cell Therapy Product
 Table 80. CARsgen Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2019-2024) & (US$ Million)
 Table 81. CARsgen Therapeutics Recent Development
 Table 82. Cartesian Therapeutics Company Details
 Table 83. Cartesian Therapeutics Business Overview
 Table 84. Cartesian Therapeutics Aldult CAR T-cell Therapy Product
 Table 85. Cartesian Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2019-2024) & (US$ Million)
 Table 86. Cartesian Therapeutics Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. Aldult CAR T-cell Therapy Picture
 Figure 2. Global Aldult CAR T-cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Aldult CAR T-cell Therapy Market Share by Type: 2023 VS 2030
 Figure 4. CD19 Features
 Figure 5. BCMA Features
 Figure 6. Others Features
 Figure 7. Global Aldult CAR T-cell Therapy Market Size by Application (2024-2030) & (US$ Million)
 Figure 8. Global Aldult CAR T-cell Therapy Market Share by Application: 2023 VS 2030
 Figure 9. Multiple Myeloma Case Studies
 Figure 10. B-Cell Lymphoma (BCL) Case Studies
 Figure 11. Acute Lymphoblastic Leukemia (ALL) Case Studies
 Figure 12. Others Case Studies
 Figure 13. Aldult CAR T-cell Therapy Report Years Considered
 Figure 14. Global Aldult CAR T-cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Aldult CAR T-cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Aldult CAR T-cell Therapy Market Share by Region: 2023 VS 2030
 Figure 17. Global Aldult CAR T-cell Therapy Market Share by Players in 2023
 Figure 18. Global Top Aldult CAR T-cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aldult CAR T-cell Therapy as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Aldult CAR T-cell Therapy Revenue in 2023
 Figure 20. North America Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Aldult CAR T-cell Therapy Market Share by Country (2019-2030)
 Figure 22. United States Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Aldult CAR T-cell Therapy Market Share by Country (2019-2030)
 Figure 26. Germany Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Aldult CAR T-cell Therapy Market Share by Region (2019-2030)
 Figure 34. China Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Aldult CAR T-cell Therapy Market Share by Country (2019-2030)
 Figure 42. Mexico Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Aldult CAR T-cell Therapy Market Share by Country (2019-2030)
 Figure 46. Turkey Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Aldult CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Bristol Myers Squibb,BMS Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2019-2024)
 Figure 50. Johnson & Johnson Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2019-2024)
 Figure 51. Gilead Sciences Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2019-2024)
 Figure 52. Novartis Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2019-2024)
 Figure 53. JW Therapeutics Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2019-2024)
 Figure 54. Imunopharm Technology Co., Ltd. Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2019-2024)
 Figure 55. CARsgen Therapeutics Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2019-2024)
 Figure 56. Cartesian Therapeutics Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2019-2024)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India